Skip to main content
. 2019 Sep 9;41(1):786–793. doi: 10.1080/0886022X.2019.1657894

Table 1.

Baseline characteristics of 866 MHD patients.

Characteristics Total (n = 866) Mean ± SD/ Median (interquartile range) Normal range in CGMH
Demographics    
 Age (y) 56.18 ± 13.59  
 Male, n (%) 440 (50.8%)  
 Body mass index (kg/m2) 22.19 ± 3.18  
 Smoking, n (%) 150 (17.3%)  
Co-morbidity    
 Diabetes mellitus, n (%) 192 (22.2%)  
 Hypertension, n (%) 339 (39.1%)  
 Previous CVD, n (%) 41 (4.7%)  
 HBV, n (%) 98 (11.3%)  
 HCV, n (%) 168 (19.4%)  
 CTS, n (%) 76 (8.8%)  
Dialysis Related Data    
 Hemodialysis duration (y) 6.96 ± 5.35  
 Erythropoietin (U/kg/week) 73.62 ± 47.37  
 Fistula as blood access, n (%) 689 (79.6%)  
 Hemodiafiltration, n (%) 187 (21.6%)  
 Kt/Vurea (Daugirdes) 1.79 ± 0.32  
 nPCR (g/kg/day) 1.18 ± 0.26  
 Residual daily urine of >100 mL, n (%) 178 (20.6%)  
Biochemical Data    
 Hemoglobin (g/dL) 10.51 ± 1.36 M: 13.5–17.5
F: 12–16
 Albumin (g/dL) 4.06 ± 0.34 3.5–5.5
 Creatinine (mg/dL) 10.88 ± 2.39 M: 0.64–1.27
F: 0.44–1.03
 Ferritin (μg/L)a 305.0 (129.57, 504.45) M: 22–322
F: 10–291
 Corrected-calcium (mg/dL) 9.94 ± 0.93 7.9–9.9
 Phosphate (mg/dL) 4.84 ± 1.35 2.4–4.7
 Intact parathyroid hormone (pg/mL)a 130.1 (52.52, 319.2) ESRD: 168–342
 hsCRP (mg/L)a 2.95 (1.4, 7.01) <5
 hsCRP > 3 mg/L, n (%) 420 (48.5%)  
Cardiovascular Risks    
 Cholesterol (mg/dL) 171.3 ± 37.66 <200
 Triglyceride (mg/dL) 164.33 ± 115.8 <150
 LDL (mg/dL) 94.83 ± 30.59 <100
 BLL (ug/dL)a 10.39 (7.26, 14.19) <10

M: male; F: female; ESRD: end stage renal disease; MHD: maintenance hemodialysis; CTS: carpal tunnel syndrome; CVD: cardiovascular disease; HBV: hepatitis B virus infection; HCV: hepatitis C virus infection; nPCR: normalized protein catabolic rate; hsCRP: high-sensitivity C-reactive protein; LDL: low density lipoprotein; Kt/Vurea (Daugirdes): dialysis clearance of urea; BLL: blood lead level; CGMH: Chang Gung Memorial Hospital.

a

Non-normal distribution data are presented as median (interquartile range).